SpyGlass Pharma develops an eye lens with drug pads that releases glaucoma medicine over time, for use during cataract surgery. It last closed at $30.43 on Nov 20, down 1.14% on the day. The next earnings report for SGP is expected around Thu, Mar 25, 2027, after the close. For the quarter ended Sep 2026, SGP reported EPS of -$0.73. Over its last 4 reports the stock moved an average of 5.4% the session after earnings. Over the last 12 months SGP insiders bought $221.5M of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is SGP in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SGP.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on SGPStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
SGP · as of the Nov 20 close · updated each morning
Moving sideways
The stock sits between its 20 and 50 day averages. It is 18% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 47). The nearest support is the Pivot at $30.41, and the nearest resistance the Pivot R1 at $31.75.
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 8.0%/day
Key levels
$39.9252 week high+31.2%
$39.92Swing high (Nov 9)+31.2%
$33.0120 day average+8.5%
$31.75Pivot R1+4.3%
$30.43Last close
$30.41Pivot−0.1%
$29.09Pivot S1−4.4%
$29.0750 day average−4.5%
$27.00Swing low (Sep 15)−11.3%
$26.49100 day average−12.9%
$25.05200 day average−17.7%
$17.0652 week low−43.9%
Indicators
RSI (14)
47.06
Middle of its range
Neutral
MACD
0.68
Below its signal line
Bearish
Stochastic
16.6
Near the bottom of its range
Oversold
ADX (14)
26.5
Trending down
Williams %R
-79.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
-90.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−17.6%
Change over 10 sessions
Bearish
ATR (14)
$2.43
Typical daily range, 8.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNormal
VolatilityNormal, 13.3%/day
Key levels
$39.9252 week high+31.2%
$39.92Swing high (Nov 9)+31.2%
$33.0120 day average+8.5%
$31.75Pivot R1+4.3%
$30.43Last close
$30.41Pivot−0.1%
$29.09Pivot S1−4.4%
$29.0750 day average−4.5%
$27.00Swing low (Sep 15)−11.3%
$26.49100 day average−12.9%
$25.05200 day average−17.7%
$17.0652 week low−43.9%
Indicators
RSI (14)
55.90
Middle of its range
Neutral
MACD
2.02
Above its signal line
Bullish
Stochastic
67.4
Middle of its range
Neutral
ADX (14)
27.7
Trending up
Williams %R
-55.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
79.3
Oversold below −100, overbought above 100
Neutral
Rate of change
+10.6%
Change over 10 sessions
Bullish
ATR (14)
$4.05
Typical daily range, 13.3% of price
MA 10Above
MA 20Above
MA 50–
MA 100–
MA 200–
What happened before, for SGP
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SGP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for SGPHow many large options trades hit SGP, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in SGP in the last 90 days.
From SEC Form 4 filings by SGP's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SGP is in one of them and how their past SGP trades turned out.
SpyGlass Pharma is a biopharmaceutical company based in Irvine, California, that develops long lasting drug delivery products for people with chronic eye conditions. Its lead product candidate is an intraocular lens fitted with drug pads that releases bimatoprost, a medicine already approved for topical use, to lower eye pressure in patients with glaucoma or ocular hypertension. The lens is designed to be implanted during routine cataract surgery, so its main customers are cataract surgeons and the patients they treat. The product is still in clinical trials and is not yet approved for sale.